Companies

Humacyte, Inc. (HUMA) SEC filings

CIK 0001818382 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)2.0 M
Net income (USD)-110.8 M-12.0 M-26.5 M
Diluted EPS (USD/shares)-0.26-1.07-0.12

Latest filings

FiledFormDescriptionPeriod
2026-10-07442026-10-06
2026-10-07442026-10-06
2026-09-28332026-09-22
2026-09-28332026-09-22
2026-09-288-K8-K items 5.02,7.01,9.012026-09-22
2026-09-15442026-09-14
2026-08-2525-NSE25-NSE
2026-08-21442026-08-20
2026-08-19442026-08-17
2026-08-18SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-1210-Q10-Q2026-06-30
2026-08-128-KFORM 8-K items 2.02,9.012026-08-12
2026-07-318-KFORM 8-K items 3.012026-07-31
2026-07-28SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-13SCHEDULE 13D/ASCHEDULE 13D/A
2026-06-22SCHEDULE 13GSCHEDULE 13G
2026-06-15SCHEDULE 13D/ASCHEDULE 13D/A
2026-06-124OWNERSHIP DOCUMENT2026-06-11
2026-06-124OWNERSHIP DOCUMENT2026-06-11
2026-06-124OWNERSHIP DOCUMENT2026-06-11
2026-06-124OWNERSHIP DOCUMENT2026-06-11
2026-06-124OWNERSHIP DOCUMENT2026-06-11
2026-06-124OWNERSHIP DOCUMENT2026-06-11
2026-06-124OWNERSHIP DOCUMENT2026-06-11
2026-06-124OWNERSHIP DOCUMENT2026-06-11

Forms on file (last 1,000): 4 204, 8-K 79, 3 31, 144 24, 10-Q 18, 424B3 15, 425 13, SC 13D/A 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=HUMA (0.002 USD), /gw/filings/filings?ticker=HUMA&form=8-K, /gw/filings/facts?ticker=HUMA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange